Solana ( SOL 3.76%) holders are no stranger to risk, given the coin's wild volatility and its occasional use by unsavory ...

The tech market took it on the chin on Wednesday as the trade war picked up steam and the Federal Reserve sounds like it's ...

Lucid stock is down about 25% year to date with today's drop. News from the company yesterday was positive, though. Lucid is ...

For the inaugural quarter of 2025, Progressive's net premiums earned (essentially, total revenue) was $22.2 billion, ...

Nvidia ( NVDA -9.16%) shares fell more than 7% on Wednesday morning, after the company disclosed new export restrictions on ...

Shares of ConocoPhillips ( COP 2.69%) dipped on Tuesday after TheFly.com reported multiple bank analysts forecasting lower ...

Shares in Uranium Energy ( UEC 5.42%) rose by as much as 11.3% in morning trading as investors digested the latest news in ...

Microsoft ( MSFT -3.67%) had one of its more forgettable sessions on the stock market Wednesday, with its share price melting by 3.7% at closing time. Yet this had less to do with its own operations, ...

Nvidia ( NVDA -9.37%) stock is falling fast amid multiple bearish catalysts in Wednesday's trading. The company's share price was down 9.7% as of 3:15 p.m. ET amid a 3% pullback for the S&P 500 and a ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The analyst behind the reduction was Wedbush's David Nierengarten, who now believes NovoCure is worth $27 per share. That's slightly below his previous price target of $29. As the change isn't ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.